Tilray Stock Couldn’t Sustain Its Trump Gains. How Cannabis Earnings Could Help.
When speculation broke out that President Donald Trump could move to reschedule marijuana as a Schedule III drug before the end of 2025, cannabis stocks soared. Those gains were short-lived.
The 3 Best Cannabis Stocks to Buy for 2026
These three cannabis stocks mix regulatory optionality, steady operators, and biotech risk as investors position for 2026 reform tailwinds.
Trump’s Marijuana Order Is Lighting Up This Cannabis ETF: Momentum Score Spikes
The AdvisorShares Pure U.S. Cannabis ETF (NYSE: MSOS), which invests in U.S. marijuana and hemp stocks, is seeing a surge in Momentum in Benzinga’s Edge Stock Rankings, as Washington starts warming up …
Should You Buy ACB Stock After Marijuana Reclassification Order?
Aurora Cannabis faces uneven gains from marijuana reclassification as medical cannabis drives growth, while weak consumer sales affect optimism.
The cannabis stock correction is over, this analyst says
U.S. cannabis stocks appear to have completed their post-Executive Order pullback, says Beacon Securities analyst Russell Stanley …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Does Marijuana Rescheduling in the U.S. Make Canopy Growth a Good Buy in 2026?
The company has banked its hopes heavily on the prospects for marijuana legalization in the U.S., and it’s paid a steep price in recent years for doing so. Buying a stock based on the expectation that …
This cannabis ETF outperformed the S&P in 2025: Outlook for 2026
AdvisorShares’ Pure US Cannabis exchange-traded fund (ETF) (MSOS) outperformed the S&P 500 (^GSPC) in 2025. President Trump’s executive order rescheduling marijuana has sent the ETF surging.
10 biggest cannabis stocks in the US and Canada in 2026
After a year of stop‑start policy signals, the US cannabis market ended 2025 with a new wave of attention as US President Donald Trump moved to accelerate federal cannabis rescheduling efforts. His …
Tilray Stock Couldn’t Sustain Its Trump Gains. How Cannabis Earnings Could Help.
When speculation broke out that President Donald Trump could move to reschedule marijuana as a Schedule III drug before the end of 2025, cannabis stocks soared. Those gains were short-lived.
Trump is warming to cannabis, but investors aren’t impressed
The Trump administration is becoming friendlier toward the cannabis industry, which is good news. But after years of disappointment, faith in the industry—and a payday for investors—won’t come …
7 Best Marijuana Stocks and ETFs to Buy in 2026
In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related to rescheduling marijuana as a less-dangerous drug.
TFSA investors: An undervalued cannabis stock you can buy for $500 right now
Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December 2025. The post TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now appeared first on The Motley Fool Canada.
This cannabis stock got destroyed in 2025. Can Trump make 2026 a different story?
Cannabis stocks are once again in the spotlight for investors, with a range of companies in this sector seeing big increases over the past week. The list of cannabis companies shows extremely diverse …
This Stock Has Almost Tripled in 6 Months. Here’s What Investors Need to Watch Next
Now, it’s worth noting Stock Advisor’s total average return is 975 % — a market-crushing outperformance compared to 193% for the S&P 500. Don’t miss the latest top 10 list, available with Stock …
Recent Comments